Xintela AB (FRA:1XT) E10: €-0.02 (As of Mar. 2026)


FRA:1XT Xintela AB FRA:1XT
8 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Xintela AB E10?

Xintela AB FRA:1XT +6.25% 8 E10 is €-0.02 as of Mar. 2026. GuruFocus rates FRA:1XT with a GF Score™ of 8/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xintela AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.02 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-05), Xintela AB's current stock price is €0.0102. Xintela AB's E10 for the quarter that ended in Mar. 2026 was €-0.02. Xintela AB's Shiller PE Ratio of today is .


Xintela AB  (FRA:1XT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xintela AB E10 Related Terms


Xintela AB E10 Historical Data

* Premium members only.

The historical data trend for Xintela AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xintela AB E10 Chart

Xintela AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.05 -0.02

Xintela AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.03 -0.03 -0.02 -0.02

FRA:1XT vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Xintela AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xintela AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xintela AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xintela AB's Shiller PE Ratio falls into.


FRA:1XT
8GF Score
Xintela AB FRA:1XT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xintela AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xintela AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.002/133.5600*133.5600
=-0.002

Current CPI (Mar. 2026) = 133.5600.

Xintela AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.012 101.019 -0.016
201609 -0.007 101.138 -0.009
201612 -0.014 102.022 -0.018
201703 -0.012 102.022 -0.016
201706 -0.011 102.752 -0.014
201709 -0.011 103.279 -0.014
201712 -0.012 103.793 -0.015
201803 -0.014 103.962 -0.018
201806 -0.010 104.875 -0.013
201809 -0.007 105.679 -0.009
201812 -0.013 105.912 -0.016
201903 -0.013 105.886 -0.016
201906 -0.015 106.742 -0.019
201909 -0.011 107.214 -0.014
201912 -0.007 107.766 -0.009
202003 -0.010 106.563 -0.013
202006 -0.012 107.498 -0.015
202009 -0.008 107.635 -0.010
202012 -0.020 108.296 -0.025
202103 -0.008 108.360 -0.010
202106 -0.010 108.928 -0.012
202109 -0.012 110.338 -0.015
202112 -0.011 112.486 -0.013
202203 -0.010 114.825 -0.012
202206 -0.012 118.384 -0.014
202209 -0.010 122.296 -0.011
202212 -0.005 126.365 -0.005
202303 -0.005 127.042 -0.005
202306 -0.005 129.407 -0.005
202309 -0.002 130.224 -0.002
202312 -0.003 131.912 -0.003
202403 -0.002 132.205 -0.002
202406 -0.002 132.716 -0.002
202409 -0.001 132.304 -0.001
202412 -0.002 132.987 -0.002
202503 -0.002 132.825 -0.002
202506 -0.002 133.699 -0.002
202509 -0.001 133.480 -0.001
202512 -0.002 133.390 -0.002
202603 -0.002 133.560 -0.002

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.02 mean?
Xintela AB (FRA:1XT) has a E10 of €-0.02 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Xintela AB and its competitors.
Is Xintela AB's E10 too high?
Xintela AB's current E10 is €-0.02. Overall, Xintela AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Xintela AB's E10 compare to VRTX and REGN?
Xintela AB's E10 of €-0.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Xintela AB and its competitors. Xintela AB's current E10 is €-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xintela AB stock overvalued right now?
Xintela AB (FRA:1XT) has a current E10 of €-0.02. The current E10 is €-0.02. Xintela AB's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Xintela AB (FRA:1XT), the current E10 is €-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xintela AB Business Description

Other Exchanges XINT:Sweden
Address Medicon Village, Lund, SWE, 223 81
Xintela AB is a clinical-stage biopharmaceutical company that develops cutting-edge medical products in stem cell therapy and targeted cancer therapy. Its wholly owned subsidiary, Targinta AB, develops First-in-Class therapeutic antibodies targeting integrin ?10?1. TARG9, an antibody-drug conjugate (ADC), and TARG10, a function-blocking antibody, are in preclinical development for the treatment of aggressive, difficult-to-treat cancers, including triple-negative breast cancer and brain tumor glioblastoma. Xintela has two clinical studies ongoing with the stem cell product XSTEM and EQSTEM.
8GF Score

Get the complete analysis for FRA:1XT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price